Mitigating infection risks in patients with CLL

Jennifer Brown, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, discusses infection risks in patients with chronic lymphocytic leukemia (CLL). Efforts are underway to use a machine learning algorithm to predict high-risk patients. Current strategies for mitigating infections include vaccinations and intravenous immunoglobulins. Dr Brown also notes that CAR T-cell treatment may exacerbate hypergammaglobulinemia, a rare condition typically caused by infection. This interview took place at the 29th Congress of the European Hematology Association (EHA) in Madrid, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.